Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Caffeine and Levodopa

supplement:

Caffeine

Research Papers that Mention the Interaction

The ability of orally administered caffeine to modify the antiparkinsonian efficacy of levodopa or piribedil, a putative dopamine receptor agonist, was studied in six patients.
Neurology  •  1975  |  View Paper
At Cox regression models, higher caffeine consumption was associated with a lower rate of starting l-Dopa treatment (HR = 0.630; 95%CI = 0.382-0.996).
Parkinsonism & related disorders  •  2016  |  View Paper
Caffeine , the world's most widely used psychomotor stimulant, potentiates the antiparkinsonian effects of levodopa in preclinical models, as noted nearly 40 years ago.[1][1] The findings prompted early placebo-controlled crossover studies of caffeine as an adjunct to levodopa or a dopamine agonist
Neurology  •  2012  |  View Paper
Caffeine administered before levodopa may improve its pharmacokinetics in some parkinsonian patients.
This double-blind, randomized, crossover study revealed that caffeine shortened the maximal plasma concentration of levodopa , decreased the latency to levodopa walking and tapping motor response, and increased the magnitude of walking response.
Neurology  •  2006  |  View Paper
Caffeine , which is a known neuroprotectant, can potentially act as an adjunct to minimise adverse effects of L-DOPA.
Discussion and conclusions Taken together, we show that caffeine can protect DAergic neurons and can reduce aberrant locomotion and loss of sensation when co-administered with L-DOPA , which can potentially impact PD treatment and warrants further investigation.
Pharmaceutical biology  •  2020  |  View Paper
Coadministration of caffeine with a low dose of l-DOPA reduces dyskinesia in animals with striatopallidal knock-out to wild-type levels, suggesting a dependence on adenosine receptor activity.
The Journal of Neuroscience  •  2017  |  View Paper
Caffeine given systemically (15 mg/kg) or into the dorsal striatum or external globus pallidus (GPE; 20–40 μg) increased contralateral forepaw stepping by 14%, 27%, and 26%, respectively, and enhanced the effect of 8 mg/kg L-DOPA on stepping.
Psychopharmacology  •  2008  |  View Paper
Cross-sensitization between caffeine and L-dopa following repeated treatment and their positive interaction during chronic co-adminstration in hemiparkinsonian mice suggest that repeated exposure to caffeine may alter L-dopa responses in PD.
Furthermore, daily co-administration of caffeine plus L-dopa produced enhanced rotational behavior, compared to caffeine or L-dopa alone, indicating an additive or synergistic interaction between caffeine and L-dopa during repeated treatment.
In a cross-challenge paradigm, daily treatment of mice with L-dopa (compared to daily saline) produced a three-fold enhancement in the rotational response to a subsequent re-challenge with caffeine.
Similarly, daily treatment of mice with caffeine produced a six-fold enhancement in the rotational response to a subsequent re-challenge with L-dopa.
Neuroscience Letters  •  2006  |  View Paper
From these and earlier data it is suggested that part of the potentiating effect of caffeine on the L-DOPA induced motility is due to the increased cerebral level of dopamine and part to a catecholamine-receptor sensitizing effect of caffeine.
The accumulation of dopamine in the brain, and the levels of DOPA in both brain and plasma following administration of L-DOPA , all increased when caffeine was given beforehand.
Journal of Neural Transmission  •  2005  |  View Paper
Administration of SKF 38393 (1.5 mg/kg) or L-3,4-dihydroxyphenyl-alanine (6 mg/kg), but not quinpirole (0.15 mg/kg) or R(−)-propylnorapomorphine (0.01 mg/kg), induced a significantly higher contralateral turning behaviour in rats subchronically treated with caffeine than in vehicle-pretreated rats.
Behavioural pharmacology  •  2005  |  View Paper
Show More